Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 29, 2000
An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drugR Bakshi, I Hermeling-Fritz, I Gathmann, et al.AIDS Research and Human Retroviruses|October 1, 1990
The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophagesJ K Lazdins, K Woods-Cook, M Walker, et al.Journal of Neuroimmunology|April 1, 1988
In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attackP Martelletti, E Alteri, A Pesce, et al.Antiviral Research|April 1, 1990
Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effectsJ Lazdins, E Alteri, K W Cook, et al.International Journal of Cancer|May 15, 1989
A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activityT Meyer, U Regenass, D Fabbro, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugsC Rordorf-Adam, J Lazdins, K Woods-Cook, et al.Antiviral Chemistry & Chemotherapy|August 31, 2001
Anti-HIV-1 activity in vitro of ceftazidime degradation productsR Hobi, U Hübscher, K Neftel, et al.Antimicrobial Agents and Chemotherapy|October 1, 1993
CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activityE Alteri, G Bold, R Cozens, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytesJ K Lazdins, T Klimkait, K Woods-Cook, et al.Pageof 2